Core Viewpoint - Rosen Law Firm is reminding former stockholders of Smartsheet Inc. about a class action lawsuit related to the company's January 2025 sale to a consortium led by Blackstone, Vista Equity Partners, and Platinum Falcon, with a lead plaintiff deadline of February 24, 2026 [1] Group 1: Class Action Details - Former Smartsheet stockholders may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 24, 2026 [1] - The complaint alleges that Smartsheet's solicitation of stockholder approval for the Buyout involved a false and misleading Proxy statement that mischaracterized the company's financial performance [1] Group 2: Allegations Against Defendants - The defendants are accused of intentionally portraying Smartsheet's quarterly earnings negatively and emphasizing a fabricated financial metric to solicit approval for the Buyout [1] - Mark P. Mader, a defendant, is alleged to have failed in his disclosure duties by not exercising reasonable care [1] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [1] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [1]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Integer Holdings Corporation (NYSE: ITGR) related to shareholder interests [1]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Integer misrepresented the company's competitive position in the expanding EP manufacturing market [2]. - The lawsuit alleges that Integer overstated its visibility into customer demand while actually experiencing a decline in sales for two of its EP devices [2]. - Integer is accused of mischaracterizing its EP devices as a long-term growth driver for its C&V segment, leading to materially false and misleading statements about the company's business and prospects [2].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Avantor, Inc. related to misrepresentation of the company's competitive positioning and operational challenges [1][2]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Avantor misrepresented the company's competitive positioning, indicating it was weaker than publicly stated [2]. - The lawsuit also alleges that Avantor faced negative impacts from increased competition, which were not disclosed to shareholders [2]. - As a result of these issues, the representations regarding Avantor's business, operations, and future prospects were deemed materially false and misleading [2]. Group 2: Shareholder Actions - Shareholders who purchased AVTR shares prior to March 5, 2024, are encouraged to contact Kuehn Law for potential legal action, as the firm covers all case costs [3]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [4].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of CarMax, Inc. related to misrepresentation of the company's growth prospects [1][2]. Group 1: Investigation Details - The investigation is focused on whether CarMax insiders misrepresented or failed to disclose critical information regarding the company's growth, which was influenced by temporary factors such as customer speculation about tariffs [2]. - Allegations suggest that statements made about CarMax's business operations and future prospects were materially false and misleading, lacking a reasonable basis during relevant times [2]. Group 2: Shareholder Participation - Shareholders who purchased KMX shares prior to June 20, 2025, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3]. - The firm covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Skye Bioscience, Inc. related to misrepresentation of the company's product effectiveness and prospects [1][2]. Group 1: Legal Investigation - Kuehn Law is looking into whether Skye Bioscience's insiders misrepresented the effectiveness of nimacimab, leading to overstated clinical, regulatory, and commercial prospects [2]. - The investigation is prompted by a federal securities lawsuit alleging that public statements made by Skye Bioscience were materially false and misleading [2]. Group 2: Shareholder Participation - Shareholders who purchased SKYE shares prior to November 4, 2024, are encouraged to contact Kuehn Law to enforce their rights, as there may be limited time to act [3]. - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4].

Group 1 - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of StubHub Holdings, Inc. [1] - A federal securities lawsuit alleges that insiders at StubHub misrepresented or failed to disclose significant changes affecting the company's cash flow and vendor payments [2] - The lawsuit claims that these misrepresentations led to materially misleading reports on free cash flow and positive statements about the company's business prospects [2] Group 2 - Shareholders who purchased STUB before October 1, 2025, are encouraged to contact Kuehn Law for potential legal action [3] - Kuehn Law covers all case costs and does not charge clients, emphasizing the importance of timely action for shareholders [3] - The firm highlights the significance of shareholder participation in maintaining the integrity of financial markets [4]

Core Points - Rosen Law Firm is reminding investors of Fly-E Group, Inc. about the November 10, 2025 deadline to join a securities class action lawsuit for those who purchased shares between July 15, 2025, and August 14, 2025 [1][2] Group 1: Class Action Details - Investors who purchased Fly-E securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court by November 10, 2025, to serve as lead plaintiff, representing other class members [3][6] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4] - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [4] Group 3: Case Allegations - The lawsuit alleges that Fly-E Group provided misleading statements regarding the safety of its lithium battery, which negatively impacted E-vehicle sales revenue, despite optimistic long-term projections [5] - The company’s forecasting processes reportedly failed, leading to declining sales and increased operating expenses, ultimately affecting revenue projections [5]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Semtech Corporation, related to misrepresentations regarding the company's CopperEdge products [1] Group 1: Allegations Against Semtech - Semtech insiders allegedly caused the company to misrepresent or fail to disclose that its CopperEdge products did not meet the needs of its server rack customers or end users [1] - The CopperEdge products required specific rack architecture changes, which were not disclosed [1] - Due to the aforementioned issues, sales of CopperEdge products are expected to be lower than anticipated, and the sales ramp-up during fiscal 2026 will not occur as previously stated [1] - Positive statements regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]

Core Viewpoint - Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW) [1]. Group 1: Company Overview - Edwards Lifesciences Corporation is under scrutiny for possible fiduciary duty violations by its leadership [1]. Group 2: Legal Context - Rosen Law Firm specializes in securities class actions and shareholder derivative litigation, emphasizing the importance of selecting qualified legal counsel with a successful track record [3]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and over $438 million secured for investors in 2019 alone [3].

Core Viewpoint - Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR) [1] Company Information - Danaher Corporation is currently under scrutiny for possible fiduciary duty violations by its leadership [1] - Investors holding shares of Danaher are encouraged to seek more information through Rosen Law Firm's website [2] Rosen Law Firm Background - Rosen Law Firm specializes in securities class actions and shareholder derivative litigation, with a strong track record of success [3] - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [3] - In 2019, Rosen Law Firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [3]